Detailed price information for Pliant Therapeutics Inc (PLRX-Q) from The Globe and Mail including charting and trades.

Detailed price information for Serve Robotics Inc (SERV-Q) from The Globe and Mail including charting and trades.

From August 1, enjoy a more affordable, amazing price of PhP26,999 for innovative technology brand TECNO’s sleek PHANTOM V ...

The RealReal, Inc. (Nasdaq: REAL)—the world’s largest online marketplace for authenticated, resale luxury goods—today ...

Last patient visit completed in Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis; topline results expected in ...

Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases ...

Q2 2025 revenues were $10.2 million, up 42% from $7.2 million in Q2 2024. This represents the highest Q2 quarterly revenues in Company history. Q2 2025 gross margin was 78.3%, versus 73.2% in Q2 2024.

Annualized recurring revenue (“ARR”) of $841 million, an increase of 3% year-over-yearTotal revenue of $214 million, up 3% year-over-year; Product subscriptions revenue of $208 million, up 4% ...

Quarter Sales of $191.9 million, up 74% from a year earlier, Quarter Net Income of $51.2 million, up 138% from a year earlier, Diluted EPS $2.22 for the Quarter, up 136% from a year earlier, ...

Revenue of $61 million, up 49%52%Member Growth and Significant Progress Toward Profitability SAN FRANCISCO, Aug. 07, 2025 (GLOBE NEWSWIRE) --  Omada Health, Inc. (Nasdaq: OMDA), the virtual ...

Interest expense was $53.7 million for the quarter ended June 30, 2025, compared to $37.9 million for the quarter ended June 30, 2024. The higher expenses were primarily driven by the increases in ...